The purpose of this study was to assess the effect of implementation of a critical pathway after simultaneous pancreas-kidney transplantation on length of stay and hospital charges. Two well-matched groups were compared: 10 patients who received transplants in 1991 (before implementation of the critical pathway) and 10 patients who received transplants in 1995 (after implementation). For the initial transplant hospitalization, the critical pathway was associated with significant reductions in length of stay, total number of laboratory tests, clinical laboratory charges, and total inpatient charges with organ acquisition charges excluded. Despite the rising costs of medical care, we have designed and implemented a critical pathway for simultaneous pancreas-kidney transplantation that has stabilized hospital charges by decreasing length of stay and the number of clinical laboratory tests.
Get full access to this article
View all access options for this article.
References
1.
HarrisMHaddenWCKnowlesWCBennettPH. Prevalence of diabetes and impaired glucose tolerance and plasma glucose levels in the US population aged 20–74 years. Diabetes. 1987;36:523–534.
2.
NathanDM. Long-term complications of diabetes mellitus. N Engl J Med. 1993;3(328):1676–1684.
3.
RubinRJAltmanWMMendelsonDN. Health care expenditures for people with diabetes mellitus, 1992. J Clin Endocrinol Metab. 1994;78:809a–809f.
4.
BrownleeM. Glycosylation and diabetic complications. Diabetes. 1994;43:836–841.
5.
The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;29:977–986.
6.
RobertsonRP. Pancreas transplantation in humans with diabetes mellitus. Diabetes. 1991;40:1085–1089.
7.
SutherlandDER. Pancreatic transplantation: An update. Diabetes Rev. 1993;1:152–165.
8.
SutherlandDERGruessnerAGruessnerRWG. International Pancreas Transplant Registry (IPTR): Pancreas transplant results in the USA with comparison to non-USA data in the International Registry. In: IPTR Annual Report, 1995. Minneapolis, Minn: IPTR; 1996.
9.
SutherlandDERGruessnerA. Pancreas transplantation in the USA as reported to the United Network for Organ Sharing (UNOS) and analyzed by the International Pancreas Transplant Registry. In: TerasakiPICeckaJM, eds. Clinical Transplants 1995. Los Angeles, Calif: UCLA Tissue Typing Laboratory; 1996:49–67.
10.
EvansRW. Organ transplantation and the inevitable debate as to what constitutes a basic health care benefit. In: TerasakiPICeckaJM, eds. Clinical Transplants 1993. Los Angeles, Calif: UCLA Tissue Typing Laboratory; 1994:359–391.
11.
EvansRWManninenDLDongFB. An economic analysis of pancreas transplantation: Costs, insurance coverage, and reimbursement. Clin Transpl. 1993;7:166–174.
12.
WoodRGBaileyNOTilkemeierD. Managed care: The missing link in quality improvement. J Nurs Care Qual. 1992;6:55–65.
13.
TaylorKS. Transplants flourish under managed care. Hosp Health Netw. 1994;68(6):64–66.
14.
LenisaLCastoldiRSocciC. Cost analysis of kidney-pancreas and kidney-islet transplant. Transplant Proc. 1995;27:3061–3064.
15.
ZanderK. Nursing case management: Strategic management of cost and quality outcomes. J Nurs Adm. 1988;18:23–30.
16.
PetryshenPRPetryshenPM. The case management model: An innovative approach to the delivery of patient care. J Adv Nurs. 1992;17:1188–1194.
17.
ZanderK. Care maps: The core of cost/quality care. New Definition. 1991;6:1–3.
18.
JiulianoKKPoirierCE. Nursing case management: Critical pathways to desirable outcomes. Nurs Manage. 1991;22:52–55.
19.
NugentKE. The clinical nurse specialist as case manager in a collaborative practice model: Bridging the gap between quality and cost of care. Clin Nurse Spec. 1992;6:106–111.
20.
StetlerCDezellA. Case Management Plans: Designs for Transformation. Boston, Mass: New England Medical Center Hospitals; 1987.
21.
CohenEL. Nursing case management: Does it pay?J Nurs Adm. 1991;21:20–25.
22.
CoffeyRJRichardsJSRemmertCSLeroySSSchovilleRRBaldwinPJ. An introduction to critical paths. Qual Manag Health Care. 1992;1:45–54.
23.
McKenzieCTorkelsonNGHoltMA. Care and cost: Nursing case management improves both. Nurs Manage. 1989;20:30–34.
24.
GrudichG. The critical path system. AORN J. 1991;53:705–714.
25.
ZanderK. Focusing on patient outcome: Case management in the 90s. Dimens Crit Care Nurs. 1992;11:127–129.
26.
StrattaRJTaylorRJWeideLG. A prospective randomized trial of OKT3 versus ATGAM induction therapy in pancreas transplant recipients. Transplant Proc. 1996;28:927–928.
27.
StrattaRJTaylorRJBynonJS. Surgical treatment of diabetes mellitus with pancreas transplantation. Ann Surg. 1994;220:809–817.
28.
IglehartJK. Health care reform: The labyrinth of Congress. N Engl J Med. 1993;329:1593–1596.
29.
O'MalleyJ. Future directions: Managing the cost-quality paradigm. Crit Care Nurs Q. 1992;15:80–85.
30.
NoedelNROsterlohJFBrannanJAHaselhorstMMRamageLJLambrechtsD. Critical pathways as an effective tool to reduce cardiac transplantation hospitalization and charges. J Transpl Coordination. 1996;6:14–19.
31.
BartucciMR. The ultimate challenge: Maintain quality and provide cost-effective transplant services. J Transpl Coordination. 1993;3:1.
32.
GrossCRZehrerCL. Health-related quality of life outcomes in pancreas transplant recipients. Clin Transpl. 1992;6:165–171.
33.
NathanDMFogelHNormanD. Long-term metabolic and quality of life results with pancreatic/renal transplantation in insulin-dependent diabetes mellitus. Transplantation. 1991;52:85–91.
34.
HathawayDKHartwigMSMilsteadJElmerDEvansSGaberAO. A prospective study of changes in quality of life reported by diabetic recipients of kidney-only and pancreas-kidney allografts. J Transpl Coordination. 1994;4:12–17.
35.
MildeFKHartLKZehrPS. Pancreatic transplantation: Impact on the quality of life of diabetic renal transplant recipients. Diabetes Care. 1995;18:93–95.
36.
KiebertGMVan OosterhoutECAAVan BronswijkHLemkesHHPJGooszenHG. Quality of life after combined kidney-pancreas or kidney transplantation in diabetic patients with end-stage renal disease. Clin Transpl. 1994;8:239–245.
